Achieving complete remission after sequential treatment with docetaxel‑cabazitaxel enzalutamide in a patient with metastatic castration‑resistant prostate cancer
03/2019
MUDr. Robert Novák1; MUDr. Jana Katolická, Ph.D.1; MUDr. Jiří Vašina2
1 Onkologicko-chirurgické oddělení, FN u sv. Anny, Brno
2 Oddělení nukleární medicíny, Masarykův onkologický ústav, Brno
SUMMARY
In our case report, we present a case of a patient initially with locally-regionally advanced prostate cancer. The complete remission was achieved after sequential treatment of docetaxel-cabazitaxel-enzalutamide, with maintaining good quality of life.
Key words
prostate cancer, docetaxel, cabazitaxel, enzalutamide, quality of life
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...